Genfit S.A.
Genfit S.A. (GNFT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNFT · as of Jun 8, 2026
Key Statistics
Explore Genfit S.A. Data
gnft stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The GNFT analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $13.00, representing +45.25% upside from the current price of $8.95.
Competitors & Peers
gnft competitorsGNFT
ARMP
EPRX
IVA
IVVD
MDWDStock Performance
Full HistoryAbout Genfit S.A.
Genfit S.A. operates as a biopharmaceutical company dedicated to discovering and advancing novel therapeutic candidates and diagnostic solutions for a range of metabolic and liver-related diseases. It…
what is genfit s.a. · gnft stock overview · genfit s.a. company profile · who is genfit s.a. ceo · gnft NASDAQ · genfit s.a. headquarters · genfit s.a. business segments
About Stock Overview & Key Data
Genfit S.A. (GNFT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 27, 2019. As of the latest trading session, GNFT stock price is $8.95, with a market capitalization of $445.7M. The stock has returned +166.37% over the past 12 months and +48.42% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Genfit S.A. stock is Buy, with an average 12-month price target of $13.00. In fiscal year 2024, Genfit S.A. reported revenue of $67.0M and net income of $1.5M. For detailed data — including Genfit S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genfit S.A. (GNFT) stock price is $8.95. The stock is traded on NASDAQ under the ticker symbol GNFT. The 52-week range is $2.55 – $10.00.